AA
GMAB icon

Ancora Advisors’s Genmab GMAB Stock Holding History

Ancora Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18K Sell
43
-76
-64% -$2.02K ﹤0.01% 1843
2026
Q1 		$3.19K Sell
119
-519
-81% -$15.6K ﹤0.01% 2065
2025
Q4 		$19.6K Buy
+638
New +$19.9K ﹤0.01% 1567

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Ancora Advisors's GMAB Position: Q2 2026 in Review

Ancora Advisors reduced its Genmab (GMAB) stake by 64% in Q2 2026, selling an estimated $2.02K and leaving 43 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

Ancora Advisors first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $19.6K in Q4 2025. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Ancora Advisors held 43 shares of Genmab worth $1.18K as of Q2 2026.
  • Ancora Advisors sold 76 Genmab shares in Q2 2026, an estimated $2.02K.
  • Genmab made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1843 holding.
  • Ancora Advisors first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • Ancora Advisors's Genmab position peaked at $19.6K in Q4 2025.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.